Literature DB >> 2842469

Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment.

C N Montero1, F Hefti.   

Abstract

We earlier reported that chronic intraventricular injections of NGF into adult rats with partial transection of the fimbria prevent the lesion-induced disappearance of cholinergic neurons in the medial septal nucleus and the diagonal band of Broca (Hefti, 1986). The present study assessed the specificity and treatment requirements of this effect of NGF. Immunohistochemical visualization of NGF receptors (NGF-R) revealed that these molecules are selectively located in forebrain cholinergic neurons of unlesioned brains. Fimbrial transection resulted in transient accumulation of NGF-R in proximal stumps of lesioned axons but failed to induce the expression of NGF-R by other cells in the septal area or near the lesion. Two to three weeks after lesioning, the number of septal neurons expressing NGF-R was reduced by approximately 50% in parallel with the reduction of the number of neurons expressing cholinergic marker enzymes. Repeated intraventricular NGF injections during 4 weeks prevented the disappearance of these cells. Fimbrial transections also reduced the number of septal GABAergic neurons visualized by glutamate decarboxylase immunohistochemistry. The loss of GABAergic neurons was not prevented by NGF. These findings suggest that NGF prevents the lesion-induced degeneration of cholinergic neurons by directly acting on NGF-R expressed by cholinergic cells and that NGF does not affect any neuron with an axonal lesion. Delayed start of the NGF treatment failed to prevent the disappearance of lesioned cholinergic neurons, providing evidence that NGF treatment indeed promotes the survival of these cells rather than simply upregulating the expression of transmitter-specific enzymes. A single injection of NGF at the time of the lesion was not sufficient to prevent the lesion-induced degeneration of cholinergic neurons. Furthermore, termination of chronic NGF treatment after 4 weeks was followed by loss of septal cholinergic neurons after an additional 4 weeks. These findings suggest that the continuous presence of NGF during more than 4 weeks is required to prevent the degeneration of cholinergic cells. The data are discussed in the context of a possible physiological role of NGF in the function of adult forebrain cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842469      PMCID: PMC6569415     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  23 in total

1.  Nerve growth factor in the hippocamposeptal system: evidence for activity-dependent anterograde delivery and modulation of synaptic activity.

Authors:  Lan Guo; Mason L Yeh; Verginia C Cuzon Carlson; Erin M Johnson-Venkatesh; Hermes H Yeh
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

2.  Nerve growth factor-induced derepression of peripherin gene expression is associated with alterations in proteins binding to a negative regulatory element.

Authors:  M A Thompson; E Lee; D Lawe; E Gizang-Ginsberg; E B Ziff
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 3.  Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system.

Authors:  Lisa N Pettingill; Rachael T Richardson; Andrew K Wise; Stephen J O'Leary; Robert K Shepherd
Journal:  IEEE Trans Biomed Eng       Date:  2007-06       Impact factor: 4.538

4.  Blot and culture analysis of neuronotrophic factors in nerve regeneration chamber fluids.

Authors:  D J Bates; J A Ranford; D C Mangelsdorf
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

5.  Transplant of embryonal nervous tissue preserves the responses of rat retinal ganglion cells after section of the optic nerve.

Authors:  A Gravina; L Domenici; N Berardi; L Galli; L Maffei
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

Review 6.  Growth factors: potential therapeutic applications in neurology.

Authors:  J Drago; T J Kilpatrick; S A Koblar; P S Talman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

7.  TrkA activation is sufficient to rescue axotomized cholinergic neurons.

Authors:  C A Lucidi-Phillipi; D O Clary; L F Reichardt; F H Gage
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

8.  Effect of nerve growth factor on delayed neuronal death after cerebral ischaemia.

Authors:  K Tanaka; T Tsukahara; N Hashimoto; N Ogata; Y Yonekawa; T Kimura; T Taniguchi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells.

Authors:  S Mansour-Robaey; D B Clarke; Y C Wang; G M Bray; A J Aguayo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs.

Authors:  Martijn J H Agterberg; Huib Versnel; Lotte M van Dijk; John C M J de Groot; Sjaak F L Klis
Journal:  J Assoc Res Otolaryngol       Date:  2009-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.